Browsing: Humira
If there is one thing that all stakeholders in the prescription drug supply chain can agree on it’s that patients’…
In a unique legal challenge, the Dutch Pharmaceutical Accountability Foundation is taking on the manufacturer of Humira (adalimumab), AbbVie, in…
Beginning in 2023, five years after their European counterparts, patients in the United States prescribed the autoimmune disease treatment Humira…
Biosimilars offer clinically effective treatment alternatives to branded reference drugs at a lower cost. These products are making inroads in…
According to a federal government Medicare Payment Advisory Commission report published last month, more than 40% of Medicare beneficiaries still…